Featured
Read our handpicked blogs, curated for you.
|
Data silos in pharma are the invisible barrier holding back digital transformation. On paper, Indian companies are…
|
Pharma Content Ops is quickly becoming a boardroom topic in India. For years, marketing leaders treated content…
|
AI in Indian pharma is one of the most overused phrases in boardrooms today. Every CMO has seen slick vendor slides…
Recent releases
|
UCPMP 2024 Guidelines: What Every Pharma Marketer Needs to Know
The UCPMP 2024 guidelines are not just another regulatory update. They mark a decisive shift in how pharmaceutical marketing in India will be judged, tracked, and held accountable. For years, pharma…
|
Five Proven Ways to Cut MLR Approval Time in Pharma
Do you know why MLR approval is the silent killer of pharma campaigns? Every pharma marketer in India knows the frustration. You have a campaign ready, the creative is aligned, the channels are set,…
|
UCPMP 2024 Guide to Pharma Marketing Compliance and Faster MLR
Introduction: Why UCPMP 2024 Is a Turning PointUCPMP 2024 is not another guideline update. It is a reset for how pharma marketing works in India. For years, many companies have navigated compliance…
|
AI in Pharma and Healthcare: AI use cases that actually drive pharma scripts
The conversation around AI in Pharma and Healthcare has been dominated by hype. Predictions about robots replacing reps, algorithms discovering blockbuster drugs overnight, and chatbots taking over…
